Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK3 | P27361 | 12/20 | 0.37 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.34 |
| ▸ | CCNK | O75909 | 2/20 | 0.34 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.34 |
| ▸ | CDK2 | P24941 | 2/20 | 0.34 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.34 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.34 |
| ▸ | CDK9 | P50750 | 1/20 | 0.34 |
| ▸ | ULK1 | O75385 | 1/20 | 0.34 |
| ▸ | CDK7 | P50613 | 1/20 | 0.33 |
| ▸ | CCNH | P51946 | 1/20 | 0.33 |
| ▸ | MNAT1 | P51948 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25418820 | 1.00 | MAPK3 (0.37) | MAPK3PTK2P2RX7CCNKCCNE1 | |
| SCHEMBL25524693 | 1.00 | MAPK3 (0.37) | MAPK3PTK2P2RX7CCNKCCNE1 | |
| SCHEMBL25524694 | 1.00 | MAPK3 (0.37) | MAPK3PTK2P2RX7CCNKCCNE1 | |
| SCHEMBL30396844 | 1.00 | MAPK3 (0.37) | MAPK3PTK2P2RX7CCNKCCNE1 | |
| SCHEMBL30397712 | 0.92 | MAPK3 (0.39) | MAPK3PTK2P2RX7CDK2ULK1 | |
| SCHEMBL25524691 | 0.92 | MAPK3 (0.39) | MAPK3PTK2P2RX7CDK2ULK1 | |
| SCHEMBL30397312 | 0.88 | MAPK10 (0.35) | MAPK3PTK2CCNKCDK2CDK12 | |
| SCHEMBL25419627 | 0.86 | P2RX7 (0.40) | MAPK3PTK2P2RX7CCNKCCNE1 | |
| SCHEMBL30398049 | 0.86 | P2RX7 (0.40) | MAPK3PTK2P2RX7CCNKCCNE1 | |
| SCHEMBL25532470 | 0.85 | MAPK3 (0.36) | MAPK3PTK2CCNKCDK2CDK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023091726-A1 | INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) | SYROS PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | WO | disclosed |